European Innovation Council

Established in 2020, the European Innovation Council supports innovative startups and researchers with promising ideas, focusing on early-stage companies with positive environmental, social, or governance impacts. It co-invests alongside private investors.

David Malo Jean

Director

Past deals in Technology

Astrape Networks

Grant in 2025
Astrape powers the future of datacenters: more bandwidth, less power.

VSORA

Venture Round in 2025
VSORA develops digital signal processing IP and chips for 5G networks, featuring a multicore DSP architecture that removes the need for DSP coprocessors and a shared DSP development flow that unites signal processing and software engineers in one environment to speed time-to-market. The company aims to boost DSP computing power while reducing power consumption, improving system performance, and shrinking silicon footprint. Based in France, founded in 2015 by veteran DSP engineers, VSORA serves chipmakers designing next-generation digital communications systems.

AMT Medical

Series B in 2025
AMT Medical B.V., established in 2015 and located in Ede, the Netherlands, specializes in the development of innovative medical devices for heart bypass surgery. The company's flagship product, the AMT Heart Bypass System, utilizes a minimal invasive technique known as the ELANA bypass, which was invented by neurosurgeon Prof. Dr. C.A.F. Tulleken and his research team. This advanced technology aims to enhance traditional heart bypass procedures by making them faster, safer, and less invasive, thereby improving patient outcomes and reducing complications. AMT Medical has completed the full development of its product and the production process, with all pre-clinical trials successfully concluded. The company is also preparing to initiate a clinical multi-center trial to further validate the technology's efficacy.

BlueHeart Energy

Venture Round in 2025
BlueHeart Energy is a deep tech company focused on developing innovative green technologies to enhance heat pump performance. Utilizing thermoacoustics, the company generates sound waves within a closed circuit to produce heat and cold, marking a significant advancement as this technology is now being applied to residential heat pumps, previously limited to industrial applications. BlueHeart's products are designed to replace critical components in heat pumps, facilitating easy integration for original equipment manufacturers. The resulting heat pumps are versatile, silent, and cost-effective, suitable for both new and existing homes. Additionally, BlueHeart's technology is environmentally friendly, producing no CO2 emissions and eliminating the need for refrigerants, thus contributing to sustainable heating and cooling solutions.

QDI systems

Venture Round in 2025
QDI Systems B.V. is a startup based in Groningen, the Netherlands, focused on developing advanced imaging devices for medical applications using quantum dot technology. The company specializes in creating X-ray sensors that deliver high-contrast and high-resolution imaging, particularly for mammography, while also reducing radiation exposure for patients. QDI Systems aims to provide user-friendly quantum dot materials accompanied by comprehensive instructions for constructing high-performance imaging devices. By leveraging innovative technology, the company enhances the precision of medical imaging, enabling healthcare professionals to obtain critical diagnostic information efficiently and safely.

QDI systems

Grant in 2025
QDI Systems B.V. is a startup based in Groningen, the Netherlands, focused on developing advanced imaging devices for medical applications using quantum dot technology. The company specializes in creating X-ray sensors that deliver high-contrast and high-resolution imaging, particularly for mammography, while also reducing radiation exposure for patients. QDI Systems aims to provide user-friendly quantum dot materials accompanied by comprehensive instructions for constructing high-performance imaging devices. By leveraging innovative technology, the company enhances the precision of medical imaging, enabling healthcare professionals to obtain critical diagnostic information efficiently and safely.

Elicera Therapeutics

Grant in 2025
Elicera Therapeutics is a clinical-stage immuno-oncology company based in Sweden that focuses on developing innovative cell and gene therapies to treat cancer. The company’s portfolio includes four drug candidates: two oncolytic virus therapies, ELC-100 and ELC-201, and two CAR T-cell treatments, ELC-301 and ELC-401. Additionally, Elicera has developed a universal CAR T-cell technology platform named iTANK (ELC-001), designed to enhance the efficacy of CAR T-cell therapies by enabling a multi-targeted approach against solid tumors. With its commitment to advancing immune-based cancer treatments, Elicera Therapeutics aims to improve outcomes for patients facing various forms of cancer.

TENSIVE

Series A in 2025
TENSIVE s.r.l. is a biomedical company based in Milan, Italy, founded in 2012. It specializes in the development of innovative prostheses for natural breast reconstruction and augmentation. The company's products utilize biodegradable synthetic biomaterials and feature an internal micro-architecture that mimics blood vessel structures. These vascularized prostheses aim to enhance the quality of life for patients undergoing treatment for breast cancer, offering a solution that reduces the need for recurrent and costly surgical interventions. Through its focus on advanced biomaterials and design, TENSIVE seeks to provide effective and sustainable options for breast reconstruction.

.Lumen

Venture Round in 2025
Dotlumen is a research startup founded in 2020 and based in Cluj, Romania, focused on enhancing the quality of life for visually impaired individuals. The company develops innovative glasses equipped with a sensory and feedback system that aids users in navigating their environments. By leveraging advancements in artificial intelligence, robotics, and neuroscience, Dotlumen aims to empower blind individuals to better understand and interact with the world around them.

AQLAS

Grant in 2025
AQLAS is shaping the quantum future and discovering Next-Gen Lasers redefining quantum computing. Our high-quality hardware is set apart by its economical, compact, and efficient nature, thus paving the way for the proliferation of quantum computers.

ION-X

Series A in 2024
ION-X develops electric propulsion technology for small spacecraft and satellites. It focuses on a nanoscience-based thruster that ejects fully ionized particles to produce thrust, offering long service life and high modularity. The technology aims for scalable manufacturing with competitive production costs suitable for mass production, enabling customers to access the expanding aerospace market and pursue efficient, reliable propulsion for small platforms.

Onward

Grant in 2024
Onward is a medical technology company focused on developing therapies aimed at enabling functional recovery for individuals with spinal cord injuries. The company is creating an Implantable Neuro-stimulation System (INS) that features real-time motion feedback and utilizes training tools for rehabilitation. Onward has developed two platforms for neurostimulation: ARCIM, an implantable system, and ARCEX, a non-invasive transcutaneous system. To establish its customer base, Onward has targeted the United States and four European markets, namely Germany, France, the United Kingdom, and the Netherlands.

AISPECO

Grant in 2024
AISPECO is a Lithuanian company specializing in geospatial monitoring systems for helicopters, planes, UAVs, and terrestrial vehicles.

Quantune Technologies

Grant in 2024
Quantune Technologies is a deep tech startup specializing in optics and photonics technology. The company focuses on developing advanced infrared spectrometers that facilitate continuous and non-invasive health monitoring. By miniaturizing traditional laboratory equipment used for molecular analysis into compact modules, Quantune enables both biomedical consumer devices and industrial applications. This innovation allows clients to efficiently conduct real-time monitoring and analysis of chemical compounds and emissions, providing accessible solutions for a range of novel applications.

Treble

Series A in 2024
Treble Technologies is a company that focuses on advanced wave-based sound simulation products tailored for the architecture, engineering, and construction (AEC) industry. It offers specialized acoustics design software that enables the creation of physically accurate and perceptually realistic virtual acoustics. This software aids in minimizing risks and ensuring that designs adhere to all relevant regulations and certification standards. Additionally, it streamlines the process of importing, exporting, and reconfiguring models, ultimately saving time and costs for users. Treble's services find applications across various sectors, including automotive design, building architecture, immersive reality, and artificial intelligence, supporting studios and artists in delivering high-quality projects.

Wattalps

Series A in 2024
Wattalps is a technology company specializing in the development of lithium power systems tailored for small and medium-scale applications. Their product portfolio focuses on affordability, passive safety measures, efficient cooling mechanisms, extended lifespan, and robust cell protection features. Wattalps aims to simplify integration into vehicles or charging stations by offering standard and modular products, thereby facilitating swift, efficient, and cost-effective adoption of electric vehicle technologies and sustainable transportation solutions.

Oryl Photonics

Grant in 2024
Oryl Photonics specializes in developing laboratory instruments for pharmaceutical and biotech companies. Their core product provides a simple, reliable, and cost-effective method for measuring solubility, contributing to accelerated drug development and improved medicine. The company's unique technology preserves valuable substances during testing, offering a solubility measurement service that empowers researchers to make data-driven decisions and expedite product development.

Onego Bio

Venture Round in 2024
Onego Bio is a biotechnology company focused on producing animal-free egg white protein through precision fermentation. Their flagship product, Bioalbumen, offers a sustainable alternative to traditional egg proteins, boasting identical taste and nutritional profiles while providing superior functional properties and a significantly reduced environmental footprint. By employing commercially proven technology, Onego Bio meets the growing demand for stable and sustainable functional ingredients within the food industry. The company has gained recognition as a leader in innovation, winning Fast Company’s 2023 World Changing Ideas award. Additionally, Onego Bio is actively involved in the industry as a co-founder of the Precision Fermentation Alliance and Food Fermentation Europe, further establishing its commitment to advancing sustainable food solutions.

.Lumen

Venture Round in 2024
Dotlumen is a research startup founded in 2020 and based in Cluj, Romania, focused on enhancing the quality of life for visually impaired individuals. The company develops innovative glasses equipped with a sensory and feedback system that aids users in navigating their environments. By leveraging advancements in artificial intelligence, robotics, and neuroscience, Dotlumen aims to empower blind individuals to better understand and interact with the world around them.

Dynelectro

Grant in 2024
Dynelectro is a green energy technology company dedicated to minimizing CO2 emissions by converting fossil fuels into sustainable green fuels. It operates as a boutique innovation firm that specializes in advancing power-to-x systems. Dynelectro employs a proprietary method that significantly enhances the lifespan of high-efficiency electrolysis, allowing organizations to effectively offset intermittent power supply through the production of green fuels. This commitment to innovative solutions positions Dynelectro at the forefront of the transition to cleaner energy alternatives.

UroMems

Series C in 2024
UroMems is a medical device company dedicated to addressing specific clinical needs related to urinary conditions that significantly impact patients' quality of life. The company specializes in the design, development, and commercialization of active implantable medical devices. Its innovative approach aims to enhance existing surgical treatments by minimizing associated side effects and ensuring that patients receive appropriate care promptly. Through its commitment to improving treatment options, UroMems seeks to benefit a wide range of patients facing urinary health challenges.

Qblox

Series A in 2024
Qblox is a Dutch scaleup specializing in quantum technology, focused on developing patented solutions for the scalable control of quantum computers. The company designs and manufactures modular control hardware that simplifies the experimental setups involving qubits, employing a distributed processor architecture to enhance gate fidelities. By advancing electronics with improved noise and drift performance, Qblox enables scientists to minimize crosstalk and achieve low-latency arbitrary control flows while optimizing measurement efficiency in dynamic readout conditions. The company aims to address the scientific and engineering challenges that must be overcome to transition from prototype quantum computers to powerful, practical quantum processors.

iOnctura

Series B in 2024
iOnctura is a biopharmaceutical company specializing in the development of novel therapeutics aimed at addressing immunosuppression within the tumor microenvironment, which plays a significant role in cancer progression. The company seeks to enhance existing immune checkpoint therapies by creating new drugs that, when used in conjunction with these therapies, may improve safety and efficacy for cancer patients. iOnctura has formed strategic partnerships with prominent organizations, including Merck and Cancer Research Technology, to advance a pipeline of preclinical molecules toward clinical application. With access to advanced drug discovery labs and a network of academic collaborators, iOnctura is well-equipped to develop innovative combination therapies in the realm of cancer immunology, ultimately striving to optimize treatment outcomes for patients.

Bank of Memories

Grant in 2024
Bank of Memories operates a digital platform for long-term preservation of personal data, enabling users to store and organize various forms of digital memories, such as photos, videos, and documents. The platform employs blockchain technology and decentralized storage to ensure data security and longevity, allowing individuals and families to pass on their memories across generations. It offers features like digital monuments for commemorative purposes and a dedicated data room for secure storage, along with an explorer tool for navigating stored information and a whitepaper detailing the platform's technology.

Tilkal

Venture Round in 2024
Tilkal develops a software infrastructure that organizes traceability across various supply chain stakeholders. Founded in 2017, the company is headquartered in Paris, France.

3deus Dynamics

Venture Round in 2024
3Deus Dynamics is a pioneering company specializing in advanced three-dimensional printing solutions. It has developed an innovative hybrid technology that combines elements of 3D printing and traditional injection molding, allowing for the processing of a wide range of polymers without the need for chemical reformulation. This technology eliminates the requirement for support structures and overcomes design geometry limitations, enabling the creation of complex products. The company's dynamic modeling capabilities enhance its manufacturing process by simulating composite materials, which facilitates the production of items tailored to specific functional properties. As a result, 3Deus Dynamics offers clients the flexibility to print a diverse array of products on demand, positioning itself at the forefront of the 3D printing industry.

Basemark

Series B in 2024
Basemark specializes in developing augmented reality software for enhanced driver awareness and safety. It offers tools to avoid occlusion, prevent motion sickness, and support multiple in-vehicle displays, enabling automotive manufacturers to create practical AR applications.

BOYDSense

Venture Round in 2024
BOYDSense is a medical device company founded in 2015 and headquartered in South San Francisco, California. The company specializes in developing non-invasive and affordable tools for measuring critical biomarkers through exhaled breath. BOYDSense focuses on breath-based metabolomics, which involves capturing, identifying, and quantifying volatile organic compound (VOC) biomarker patterns found in human breath. This innovative approach enables medical professionals to simplify the monitoring, screening, and risk stratification of chronic diseases, facilitating more effective diagnosis and ongoing management of these conditions.

DRONAMICS

Grant in 2024
Dronamics is a developer of advanced unmanned aerial systems aimed at transforming airfreight logistics. By creating a new type of small, unmanned cargo airplane that is highly fuel-efficient, Dronamics aims to democratize shipping in emerging markets. The aircraft can transport payloads of 350 kilograms over distances of 2,500 kilometers at costs significantly lower than traditional air transport, reducing shipping expenses by over 50%. Designed for autonomous flight, the aircraft can be remotely monitored and managed via satellite, making it suitable for challenging delivery scenarios, including remote and mountainous regions. As the first and only Strategic Partner for drones recognized by IATA, Dronamics is positioned to make a substantial impact in the commercial logistics sector.

Wavess

Grant in 2024
Wavess is an innovative predictive marketing analytics platform that uses advanced AI algorithms and behavioral science to forecast campaign success before launch. It primarily serves digital marketing agencies, scale-ups, and enterprises in fintech, retail, and technology sectors, providing insights into audience preferences for personalized marketing strategies.

Sentante

Seed Round in 2023
Sentante is a medical technology company specialising in the development of robotic teleoperated systems for endovascular procedures. Their core product enables physicians to perform complex surgeries remotely, reducing their exposure to harmful X-rays and expanding telesurgery capabilities.

Quantum Diamonds

Seed Round in 2023
Quantum Diamonds specializes in the development of nitrogen-vacancy (NV) diamonds for quantum sensing applications. The company designs advanced quantum sensors capable of measuring magnetic fields, temperature, and pressure, offering enhanced sensitivity and resolution compared to traditional sensors. These sensors enable a range of applications, including navigation, bio-imaging, geographical surveying, and spectroscopy, even under challenging conditions. Quantum Diamonds focuses on optimizing performance in areas such as crystal lattice strain, Rabi contrast, and charge state stability, catering to both industrial and academic customers seeking innovative solutions in quantum mechanics.

Efenco

Grant in 2023
Efenco is a cleantech startup focused on enhancing the energy conversion efficiency of industrial furnaces and boilers while minimizing their carbon emissions. The company has developed a patented high-energy ray ceramic chip (HERC) that significantly reduces CO2 emissions and fuel costs by at least 18% in energy-intensive sectors, including electricity generation, steel manufacturing, pulp and paper production, ceramics, cement, and district heating. By leveraging principles from quantum and plasma physics, nanotechnology, and electrochemistry, Efenco's innovative technology captures and converts waste heat generated during natural gas combustion into a flux of ionizing radiation, thereby enabling industries to optimize energy usage and improve thermal conversion efficiency.

Quandela

Series B in 2023
Quandela is a company focused on advancing quantum computing technology, specifically in the realms of communication networks and optical computers. It specializes in manufacturing photonic quantum computers, which it supplies to industrial clients. A key innovation from Quandela is its single-photon source device, which integrates photonics with semiconductor quantum dots. This device enables the efficient collection of emitted single photons at high rates, significantly reducing charge noise decoherence and facilitating the emission of identical photons with high fidelity. Such capabilities are essential for the development of advanced quantum applications in communication, computation, and sensing, positioning Quandela as a pivotal player in the quantum technology landscape.

VSORA

Grant in 2023
VSORA develops digital signal processing IP and chips for 5G networks, featuring a multicore DSP architecture that removes the need for DSP coprocessors and a shared DSP development flow that unites signal processing and software engineers in one environment to speed time-to-market. The company aims to boost DSP computing power while reducing power consumption, improving system performance, and shrinking silicon footprint. Based in France, founded in 2015 by veteran DSP engineers, VSORA serves chipmakers designing next-generation digital communications systems.

PASQAL

Grant in 2023
Pasqal SAS, founded in 2019 and headquartered in Paris, France, specializes in the manufacture of quantum information processors utilizing atomic arrays. The company focuses on developing full-stack quantum computing technology that simulates complex phenomena to facilitate scientific discovery. Its innovative approach employs qubits made of neutral atoms organized in large two-dimensional and three-dimensional arrays, which enables analog computing. This technology addresses a variety of challenges, including optimization, drug discovery, and machine learning, empowering organizations to tackle complex problems across these fields.

Swisspod Technologies

Grant in 2023
Founded in 2019, Swisspod Technologies specializes in designing and developing Hyperloop vessels for tube-based transportation systems. The company aims to create energy-efficient, fully-electric pods, harnessing high-quality Swiss engineering to facilitate sustainable and efficient high-speed travel between cities.

Innitius

Convertible Note in 2023
Innitius specializes in developing diagnostic devices aimed at enhancing women's health, particularly in the context of preterm birth. Utilizing innovative torsional ultrasound technology, the company has created a patented intravaginal probe that transmits torsional waves to assess changes in tissue consistency. This technology enables medical practitioners to evaluate the risk of preterm birth and the likelihood of successful labor induction. By providing actionable diagnostics, Innitius helps healthcare providers accurately identify false indications of premature labor, thereby improving patient care and outcomes in obstetrics.

Paptic

Series A in 2023
Paptic is a manufacturing company focused on creating innovative, wood-based renewable and recyclable products that aim to replace traditional paper and plastic materials. By developing plastic bags that merge the renewability and recyclability of paper with the functional benefits of plastics, Paptic addresses critical global environmental challenges, particularly the accumulation of plastic waste. The company's products enable customers to pursue sustainable practices without compromising their everyday needs for plastic bags.

ONO

Convertible Note in 2023
Creating transformative change in urban mobility, making our cities cleaner and more enjoyable. We first focus on urban logistics, moving goods around the city in ways that are sustainable, efficient and cost-effective. Our vehicle and its modular platform system, with easily swappable modular units, meets the needs of city logistics. From moving food to flowers to furniture, the possibilities are endless. ONO’s founders, pioneer in e-mobility solutions, Beres Seelbach, former head of design at Mercedes and Volkswagen, Murat Günak, and light electric vehicle expert and engineer, Philipp Kahle, sought to rethink and reshape modern urban transportation. They put together a forward-thinking group of designers, engineers and creative thinkers who shared their vision of transforming urban mobility. ONO is a Berlin-based e-mobility company introducing a whole new category of emissions-free vehicle: the Pedal Assisted Transporter (PAT), combining the flexibility of a bicycle with the capacity and durability of a van. We offer environmentally friendly urban logistics solutions designed and optimised for cities of today.

Rockfield Medical Devices

Venture Round in 2023
Rockfield Medical Devices is a forward-thinking small to medium enterprise focused on human-centered design within the medical device sector. Founded by an industry expert, the company comprises a team of recognized professionals from medical device research and design. Rockfield is dedicated to becoming a global leader in the enteral feeding market, aiming to enhance user satisfaction through innovative, plug-and-play technologies that prioritize design, usability, and mobility. The company's platform significantly improves the mobility and quality of life for individuals relying on tube feeding, while also streamlining technical support and reducing maintenance costs for sales partners. By offering a user-friendly, lightweight, and discreet mobile feeding system, Rockfield Medical Devices seeks to transform service models in the enteral feeding community.

Lace Lithography

Seed Round in 2023
Lace Lithography is a technology company specializing in the development of advanced lithography solutions for semiconductor manufacturing. Their core innovation lies in a chip patterning technology that replaces traditional light-based methods with atomic-scale precision, enabling the production of smaller, more efficient chips. This breakthrough extends the limits of Moore's Law, allowing industries to continue advancing semiconductor technology in a cost-effective and energy-efficient manner.

Trisol Medical

Venture Round in 2023
Trisol Medical is a medical device company focused on addressing tricuspid regurgitation through innovative treatment solutions. The company specializes in the development of a transcatheter tricuspid replacement valve, which is engineered from a nitinol frame and features specially designed leaflets. This design effectively eliminates tricuspid regurgitation while preserving the function of the right ventricle. Trisol Medical's offerings aim to provide comprehensive treatment for patients suffering from tricuspid regurgitation and associated right ventricle dysfunction, enhancing patient outcomes and quality of life.

Scipio Bioscience

Convertible Note in 2023
Scipio Bioscience SAS is a biotechnology company based in Paris, France, founded in 2017. It specializes in manufacturing benchtop kits that provide innovative sample preparation solutions for single-cell studies. These kits are designed for use in sequencing applications across both clinical and basic research, with a particular focus on transcriptomics. Scipio Bioscience's products enable research laboratories to perform single-cell barcoding in a test tube format, facilitating more precise and efficient analysis in various scientific investigations.

Limatech

Convertible Note in 2023
Limatech designs and manufactures lithium-ion batteries for aviation, space, and defense applications, supplying power for general and commercial aviation as well as defense platforms. Its batteries are deployed across aircraft, drones, and related platforms, supporting startup and operation of piston and turbine engines through proprietary technology that prioritizes safety, reliability, and long life. The company emphasizes energy storage options that are more readily available than traditional lead and nickel-cadmium systems, delivering lightweight, durable, high-performance power sources for customers in aviation, space, and defense sectors.

Alice & Bob

Convertible Note in 2023
Alice & Bob is a Paris-based quantum computing hardware company founded in 2020. It develops universal quantum computers designed to enable industries and researchers to tackle complex problems. The company focuses on integrating error correction into its hardware, using cat qubits with built-in error resilience, and provides a platform with cloud access for remote testing and expert support. This combination aims to deliver early quantum computational advantages for practical applications in science and industry.

Aviwell

Grant in 2023
Aviwell is a company focused on enhancing animal health and growth through the development of natural and sustainable solutions. Utilizing a microbiota-based platform powered by artificial intelligence and machine learning, Aviwell operates at the intersection of digital and life sciences. The company aims to provide insights that improve animal health and performance while addressing the agri-food industry's challenges in sustainably feeding a growing global population. By prioritizing health and sustainability, Aviwell seeks to offer effective solutions at a reduced cost, ultimately contributing to better nourishment for the planet.

Hardt Hyperloop

Venture Round in 2023
Hardt Hyperloop is a company dedicated to developing an innovative transportation system that enables emission-free travel over large distances. Originating from the winning team of the SpaceX Hyperloop Competition, it aims to create a hyperloop network that serves both passengers and freight efficiently. The hyperloop system designed by Hardt Hyperloop focuses on providing a safe, sustainable, and affordable mode of transport, allowing for rapid travel between network cities with minimal waiting times. By prioritizing accessibility and environmental responsibility, Hardt Hyperloop seeks to revolutionize global mobility and enhance connectivity for daily commuters.

Wattalps

Debt Financing in 2023
Wattalps is a technology company specializing in the development of lithium power systems tailored for small and medium-scale applications. Their product portfolio focuses on affordability, passive safety measures, efficient cooling mechanisms, extended lifespan, and robust cell protection features. Wattalps aims to simplify integration into vehicles or charging stations by offering standard and modular products, thereby facilitating swift, efficient, and cost-effective adoption of electric vehicle technologies and sustainable transportation solutions.

Carthera

Series B in 2023
Carthera is a clinical-stage medtech company focused on developing innovative ultrasound-based medical devices for treating brain disorders. Its proprietary device, SonoCloud®, is an intracranial ultrasound implant that, when used in conjunction with an intravenous microbubble agent, temporarily opens the blood-brain barrier. This mechanism significantly enhances the delivery of therapeutic molecules to the brain, potentially providing new treatment options for debilitating neurological conditions. Through its technology, Carthera aims to enable healthcare professionals to address challenging brain disorders more effectively.

EBAMed

Series A in 2023
EBAMed develops a non-invasive ultrasound-based device to monitor and treat heart motion using proton beams. Founded in 2018, the company is based in Geneva, Switzerland.

Escala Medical

Grant in 2023
Escala Medical is focused on developing a pioneering medical device aimed at treating pelvic organ prolapse (POP) in women. The company has created a minimally invasive, incision-free, and mesh-free repair system that addresses the long-standing need for effective POP treatment options. This innovative device allows for a nonsurgical approach that can be performed in outpatient and office settings, ensuring a safe and quick procedure with minimal discomfort for patients. By connecting the vaginal apex to the sacrospinous ligament without incisions, Escala Medical's technology preserves organ functionality while providing a much-needed solution for those affected by POP.

Escala Medical

Venture Round in 2023
Escala Medical is focused on developing a pioneering medical device aimed at treating pelvic organ prolapse (POP) in women. The company has created a minimally invasive, incision-free, and mesh-free repair system that addresses the long-standing need for effective POP treatment options. This innovative device allows for a nonsurgical approach that can be performed in outpatient and office settings, ensuring a safe and quick procedure with minimal discomfort for patients. By connecting the vaginal apex to the sacrospinous ligament without incisions, Escala Medical's technology preserves organ functionality while providing a much-needed solution for those affected by POP.

TreaTech

Series A in 2023
TreaTech is a Swiss cleantech company established in 2015 by engineers from the École Polytechnique Fédérale de Lausanne (EPFL). The company specializes in developing catalytic hydrothermal gasification (cHTG) technology that offers an innovative approach to wastewater treatment. This thermochemical process effectively transforms various types of liquid waste, including sewage sludge, into valuable by-products such as renewable gas, clean water, and mineral salts. TreaTech's solutions focus on eco-friendly waste disposal, aligning with sustainable development and circular economy principles. By recycling wastewater and its by-products, TreaTech enables clients to manage waste more sustainably while generating resources like fertilizers and biogas.

Sensoneo

Series A in 2023
Sensoneo is a global provider of enterprise‑grade smart waste management solutions that help cities and businesses reduce costs and environmental impact. The company combines in‑house ultrasonic sensors—Single, Double, Quatro, and patent‑pending Micro‑sensors—with advanced software that delivers real‑time monitoring, analytics, route planning, and vehicle load optimization. By enabling data‑driven decisions, Sensoneo’s platform can cut waste‑collection costs by at least 30 % and lower carbon emissions by up to 60 %. Its solutions are deployed in numerous locations across Europe, North America, South America, the Middle East, Australia, and New Zealand, and include incentive programs that encourage waste reduction and streamline the entire waste lifecycle.

InProTher

Seed Round in 2023
InProTher Aps is a biotechnology company based in Copenhagen, Denmark, focusing on the development of innovative vaccine technologies and candidates within the field of immunotherapy. Established in 2011, the company is dedicated to creating the first adaptive immune therapy that targets immunosuppressive genes associated with ancient retroviruses. InProTher is also engaged in the development of products aimed at combating HIV, papilloma viruses, and various forms of cancer. Through its research and development efforts, InProTher seeks to advance treatment options in the evolving landscape of immunotherapy.

AGADE

Venture Round in 2023
AGADE specializes in robotic exoskeletons. Its flagship product, AGADEXO, significantly reduces muscle fatigue and injury risks associated with repetitive tasks by providing variable support, mimicking zero-gravity movements.

Norbite

Grant in 2023
Norbite is a biotechnology research firm that specializes in converting plastic waste into sustainable products through an innovative insect-based biorefinery process. The company's technology enables the production of sustainable goods by utilizing larvae that are bio-refined to extract proteins suitable for food and animal feed. By focusing on the transformation of plastic waste, Norbite aims to provide environmentally friendly solutions while addressing the growing concerns of waste management and sustainability. Through its unique approach, the firm contributes to the development of sustainable products and services that benefit both clients and the environment.

Agurotech

Grant in 2023
Agurotech develops soil sensing technology, offering products that include robust sensors for reliable measurements, tailored irrigation recommendations, and continuous improvement of the irrigation process. Their platform provides a sensor-based weather station to offer local measurements of temperature, wind speed, direction, rainfall, and optimizes farm irrigation for crops and soils using farm data and local weather stations.

EyeLights

Series A in 2023
EyeLights is a developer of innovative motorcycle accessories focused on enhancing rider safety and experience through advanced technology. The company offers a head-up display GPS that projects crucial navigational and safety information directly into the rider's field of vision, allowing them to maintain focus on the road. This universal accessory alerts motorcyclists to potential hazards, such as sharp bends, traffic signals, and speed limits. Designed for easy installation in under five minutes, EyeLights is compatible with various helmet types, including full-face, convertible, and jet helmets. Its compact optical technology enables visibility of GPS data from over two meters away and features audio functionality for extended use of more than eight hours. The device is built to withstand adverse weather conditions, including rain and fog, while remaining lightweight at less than 100 grams. Overall, EyeLights aims to significantly enhance the safety and enjoyment of motorcycle riding.

Naco

Grant in 2023
Naco Technologies Ltd is a manufacturer and supplier of advanced nano-coating technologies, specializing in high-performance coatings for various industries including tooling, automotive, aerospace, and microchip production. Founded in 2009 and headquartered in Riga, Latvia, Naco develops multilayer and multicomponent coatings that enhance equipment performance by providing oil-enhanced, wear-protective, thermal barrier, and liquid-repellent properties. The company plays a significant role in the hydrogen sector by creating specialized coatings for Green Hydrogen systems, such as electrolyzers and fuel cells, which improve the reliability of these systems while minimizing the use of costly and scarce materials. In 2015, Naco Technologies was acquired by the Schaeffler Group, a Germany-based company, further strengthening its capabilities and market reach.

Samplix

Grant in 2023
Samplix is a biotechnology company based in Herlev, Denmark, that specializes in advanced sample preparation for single DNA and RNA molecules. The company has developed the proprietary Xdrop™ technology, which utilizes a unique "water-oil-water" droplet formation to create millions of reaction chambers for handling individual DNA molecules. This innovative technology allows for targeted enrichment of large DNA fragments, addressing the limitations of existing multi-molecule preparation methods. By enabling precise and sensitive sample preparation, Samplix empowers researchers to conduct more informed studies, facilitating the sequencing of genetic regions critical for understanding virus integration and minimizing unintended CRISPR edits. The Xdrop™ system includes both the instrumentation and consumables needed for effective single-molecule analysis, thereby enhancing the ease of use and efficiency in molecular research.

Samplix

Venture Round in 2023
Samplix is a biotechnology company based in Herlev, Denmark, that specializes in advanced sample preparation for single DNA and RNA molecules. The company has developed the proprietary Xdrop™ technology, which utilizes a unique "water-oil-water" droplet formation to create millions of reaction chambers for handling individual DNA molecules. This innovative technology allows for targeted enrichment of large DNA fragments, addressing the limitations of existing multi-molecule preparation methods. By enabling precise and sensitive sample preparation, Samplix empowers researchers to conduct more informed studies, facilitating the sequencing of genetic regions critical for understanding virus integration and minimizing unintended CRISPR edits. The Xdrop™ system includes both the instrumentation and consumables needed for effective single-molecule analysis, thereby enhancing the ease of use and efficiency in molecular research.

inbiome

Grant in 2023
Inbiome is a trailblazing company in molecular diagnostics, specializing in proprietary molecular culture technology. This innovation enables swift bacterial testing and microbiome analysis, significantly expediting the process compared to traditional methods. The company's primary mission is to advance clinical microbiology by focusing on microbial detection and product development, thereby guiding clinicians towards more accurate and timely diagnoses. By offering advanced molecular technology for microbiome analysis, Inbiome aids in enhancing the understanding of bacteria in the human body, facilitating correct treatments, and mitigating unnecessary complications, costs, and anti-microbial resistance.

Quantune Technologies

Grant in 2023
Quantune Technologies is a deep tech startup specializing in optics and photonics technology. The company focuses on developing advanced infrared spectrometers that facilitate continuous and non-invasive health monitoring. By miniaturizing traditional laboratory equipment used for molecular analysis into compact modules, Quantune enables both biomedical consumer devices and industrial applications. This innovation allows clients to efficiently conduct real-time monitoring and analysis of chemical compounds and emissions, providing accessible solutions for a range of novel applications.

Molecular Attraction

Grant in 2023
Molecular Attraction is a research and development firm focused on creating innovative solutions for vector-borne disease control and eradication. The company specializes in identifying biological compounds that can influence the behavior of various vector organisms, including mosquitoes, ticks, flies, and rodents. By utilizing sustainable technology and chemical blends, Molecular Attraction aims to provide effective, long-lasting, and low-maintenance pest control solutions. Their approach is designed to enhance the efficacy of vector-borne disease management while prioritizing environmental sustainability and cost-effectiveness within the pest control industry.

Qurv

Grant in 2023
Qurv, established in 2020, specializes in developing advanced image sensor technologies and integrated solutions. The company's core business is enabling next-generation computer vision applications, catering to the growing demands of autonomous and intelligent systems. Qurv's innovative technology, built on over eight years of research, leverages current CMOS manufacturing and advanced materials to deliver high-performance, reliable, and functional solutions for XR devices, service robots, and automotive industries.

Valo Therapeutics

Grant in 2023
Valo Therapeutics is an immunotherapy company focused on developing antigen-coated oncolytic viruses as therapeutic vaccines for cancer treatment. Founded in 2016 and based in Oxford, United Kingdom, with an additional office in Helsinki, Finland, the company utilizes its innovative Valo Tx platform, which includes PeptiCRAd, an engineered human oncolytic adenovirus. This platform is designed to induce systemic anti-tumor T cell responses by transforming oncolytic adenoviruses into targeted, tissue-specific cancer vaccines without requiring the production of multiple genetically modified viruses. Valo Therapeutics is also advancing other neoantigen strategies, including PeptiENV, in collaboration with Professor Vincenzo Cerullo from the University of Helsinki, to enhance therapeutic responses against various cancer types.

Voiseed

Venture Round in 2023
Voiseed is an Italian startup focused on artificial intelligence in synthetic speech technology. The company has developed a fast and scalable AI Dubbing Platform specifically for the video game industry, enabling the creation of virtual human voices that mimic human emotions and prosody. This cloud-based software leverages advanced generative AI technologies to produce highly expressive virtual voices, allowing creators to customize vocal expressions and achieve multilingual voice conversion for various projects. By streamlining the dubbing process, Voiseed aims to reduce costs, time, and complexity, while continuously expanding its features to cater to additional sectors beyond gaming.

Modvion

Convertible Note in 2023
Modvion AB is a Swedish company founded in 2015 and based in Gothenburg, specializing in the design and development of modular wind power towers constructed from renewable composite materials. The company focuses on simplifying construction logistics and improving cost efficiency in the wind energy sector through its patented modular technology. This innovative approach enables the production of wind towers exceeding 120 meters in height while significantly reducing transportation costs, installation complexity, and the reliance on traditional steel structures. By leveraging engineered wood products, Modvion aims to enhance the economic viability of wind power projects, ultimately contributing to increased electricity production and more sustainable energy solutions.

Syntach

Private Equity Round in 2023
Syntach is a medical technology company focused on developing innovative cardiac support devices aimed at enhancing the care of individuals suffering from heart failure. The company's flagship product is a permanent, active implant designed to restore the impaired movement of the mitral valve while providing natural support to the heart. This device can be inserted using minimally invasive techniques and is smaller than traditional left ventricular assist devices (LVADs), which contributes to a better quality of life for patients and reduces the risk of complications. Syntach's technology is intended to benefit both men and women who require cardiac support.

PASQAL

Series B in 2023
Pasqal SAS, founded in 2019 and headquartered in Paris, France, specializes in the manufacture of quantum information processors utilizing atomic arrays. The company focuses on developing full-stack quantum computing technology that simulates complex phenomena to facilitate scientific discovery. Its innovative approach employs qubits made of neutral atoms organized in large two-dimensional and three-dimensional arrays, which enables analog computing. This technology addresses a variety of challenges, including optimization, drug discovery, and machine learning, empowering organizations to tackle complex problems across these fields.

Kvantify

Grant in 2023
Founded in 2022, Kvantify is headquartered in Copenhagen, Denmark. It specializes in quantum computing management software, offering solutions to address computational challenges across various industries such as life sciences, financial services, and logistics.

N2 Applied

Private Equity Round in 2023
N2 Applied is a Norwegian technology company focused on enabling farmers to produce their own sustainable fertilizer through an innovative process that utilizes slurry, air, and electricity. The company is in the pre-commercial phase and has developed a technology that allows for the local production of nitrogen-rich fertilizer from liquid organic substrates, such as livestock manure. By integrating nitrogen from the atmosphere into these substrates, N2 Applied's solution not only enhances the nitrogen content but also mitigates ammonia loss and reduces greenhouse gas emissions. The company operates its head office in Oslo/Asker and maintains a test center in Svene, with additional branches in Wageningen and York. N2 Applied's scalable process aims to eliminate the lengthy and costly supply chains associated with traditional fertilizer production, facilitating a more circular farming system. This approach not only provides farmers with cost-effective and environmentally friendly fertilizer but also contributes to on-farm reductions in methane and ammonia emissions.

iOnctura

Grant in 2022
iOnctura is a biopharmaceutical company specializing in the development of novel therapeutics aimed at addressing immunosuppression within the tumor microenvironment, which plays a significant role in cancer progression. The company seeks to enhance existing immune checkpoint therapies by creating new drugs that, when used in conjunction with these therapies, may improve safety and efficacy for cancer patients. iOnctura has formed strategic partnerships with prominent organizations, including Merck and Cancer Research Technology, to advance a pipeline of preclinical molecules toward clinical application. With access to advanced drug discovery labs and a network of academic collaborators, iOnctura is well-equipped to develop innovative combination therapies in the realm of cancer immunology, ultimately striving to optimize treatment outcomes for patients.

iOnctura

Venture Round in 2022
iOnctura is a biopharmaceutical company specializing in the development of novel therapeutics aimed at addressing immunosuppression within the tumor microenvironment, which plays a significant role in cancer progression. The company seeks to enhance existing immune checkpoint therapies by creating new drugs that, when used in conjunction with these therapies, may improve safety and efficacy for cancer patients. iOnctura has formed strategic partnerships with prominent organizations, including Merck and Cancer Research Technology, to advance a pipeline of preclinical molecules toward clinical application. With access to advanced drug discovery labs and a network of academic collaborators, iOnctura is well-equipped to develop innovative combination therapies in the realm of cancer immunology, ultimately striving to optimize treatment outcomes for patients.

3deus Dynamics

Pre Seed Round in 2022
3Deus Dynamics is a pioneering company specializing in advanced three-dimensional printing solutions. It has developed an innovative hybrid technology that combines elements of 3D printing and traditional injection molding, allowing for the processing of a wide range of polymers without the need for chemical reformulation. This technology eliminates the requirement for support structures and overcomes design geometry limitations, enabling the creation of complex products. The company's dynamic modeling capabilities enhance its manufacturing process by simulating composite materials, which facilitates the production of items tailored to specific functional properties. As a result, 3Deus Dynamics offers clients the flexibility to print a diverse array of products on demand, positioning itself at the forefront of the 3D printing industry.

CorWave

Venture Round in 2022
CorWave is a company focused on developing innovative implanted cardiac support devices aimed at improving the quality of life for patients suffering from heart failure. Its flagship product, the CorWave LVAD, employs a unique undulating disc wave pumping mechanism, which replaces traditional high-speed impellers used in current continuous flow rotary pumps. This design significantly reduces trauma to blood, thereby minimizing complications such as clotting and bleeding. The CorWave pump generates a pulsatile flow that closely resembles the natural heartbeat, addressing a key limitation of existing LVADs that provide only continuous flow. Additionally, the device's low power consumption and compact size facilitate its potential for complete implantation, enhanced by a wireless energy transfer system. Through these advancements, CorWave aims to alleviate the burdens associated with heart failure and invasive surgical procedures.

TENSIVE

Venture Round in 2022
TENSIVE s.r.l. is a biomedical company based in Milan, Italy, founded in 2012. It specializes in the development of innovative prostheses for natural breast reconstruction and augmentation. The company's products utilize biodegradable synthetic biomaterials and feature an internal micro-architecture that mimics blood vessel structures. These vascularized prostheses aim to enhance the quality of life for patients undergoing treatment for breast cancer, offering a solution that reduces the need for recurrent and costly surgical interventions. Through its focus on advanced biomaterials and design, TENSIVE seeks to provide effective and sustainable options for breast reconstruction.

LightnTec

Seed Round in 2022
LightnTec GmbH, founded in 2016 and headquartered in Karlsruhe, Germany, specializes in the development of innovative digital thin LED wallpapers. The company's flagship product, the Media-Screen-Matrix, is a lightweight, flexible, and highly transparent LED screen that can transform any façade into a dynamic media surface. Constructed from a thin-film PET substrate, this technology offers significant cost savings and energy efficiency, making it suitable for various applications, including installation on glass façades and billboards. The Media-Screen-Matrix is designed for outdoor use and can display images, videos, and text, providing clients with the ability to create immersive environments. Its modular design allows for customization in size and shape, enabling large-scale installations that can adapt to diverse architectural needs.

IonKraft

Grant in 2022
IonKraft, a German technology company, specializes in plasma coating for multi-material plastic containers. Their innovative plasma-enhanced chemical vapor deposition process enables recyclability of complex packaging, serving industries such as food, pharmaceuticals, cosmetics, and chemicals. By promoting material reduction and reuse, IonKraft aims to enhance performance while lowering costs, with support from the German Federal Ministry for Economic Affairs and Energy.

Deep Render

Grant in 2022
Deep Render is a London-based AI startup spun out from Imperial College London's Department of Computing. It develops AI-powered video and image compression technology that leverages deep learning, density estimation, unsupervised learning, and quantum techniques to improve compression efficiency. The company has proprietary, patented technology in media and biological image compression, with state-of-the-art results delivering at least a 50% efficiency gain over previous standards.

Dimenco

Venture Round in 2022
Dimenco develops and markets autostereoscopic 3D technology solutions. Founded in 2010, the company offers displays, components, software, content conversion services, and consultancy for professional and consumer applications.

Variolytics

Seed Round in 2022
Variolytics is a developer of advanced measurement technologies, specializing in mass spectrometry for environmental applications, particularly in sewage treatment plants. The company focuses on measuring all gas components, including greenhouse gases, within aeration tanks. Variolytics offers a range of products including measuring devices, sensor technologies, and monitoring systems that facilitate accurate data collection and process integration. In addition to its innovative measurement solutions, the company conducts process engineering research and development, providing expert advice and implementation services to help businesses optimize their industrial processes. By delivering insights into process dynamics, Variolytics enables companies to make informed decisions and enhance operational efficiency.

Alesi Surgical

Grant in 2022
Alesi Surgical Ltd. is a company based in Cardiff, United Kingdom, specializing in the development and commercialization of laparoscopic surgical smoke handling systems. Founded in 2009 as a spin-out from the Welsh Institute for Minimal Access Therapy, Alesi Surgical focuses on creating products that enhance the safety, efficiency, and outcomes of surgical procedures. Its innovative tools are portable and suitable for both laparoscopic and robot-assisted surgeries, utilizing electrostatic precipitation technology to eliminate surgical smoke and maintain a clear visual field during operations. The company distributes its products to hospitals across Europe, the Middle East, New Zealand, and Australia, leveraging its access to experienced surgeons and surgical trainers to identify challenges in surgical procedures and design effective solutions.

FLEXOfibers

Pre Seed Round in 2022
FLEXOfibers specializes in the manufacturing and production of recycled flexible steel fibers designed for concrete reinforcement. The company utilizes waste steel fibers generated during the tire recycling process to create high-quality steel fibers that boast significant tensile strength and flexibility. These fibers are characterized by their reduced diameter, allowing for the production of large quantities of filaments per unit of weight. By incorporating FLEXOfibers' products, clients can enhance the resistance, abrasion, and durability of concrete while also preventing micro-cracks and shrinkage. The innovative approach to recycling and fiber production positions FLEXOfibers as a leader in sustainable concrete reinforcement solutions.

Avatar Medical

Grant in 2022
Avatar Medical is a developer of a virtual reality medical platform that creates 3D patient avatars to assist surgeons in visualizing medical images. By generating interactive representations based on medical data, the platform enables clinicians to accurately and instantly access critical clinical information. This innovative approach not only enhances the understanding of surgical options but also facilitates the training of medical fellows and improves patient engagement. Avatar Medical aims to transform how medical professionals interact with imaging data, ultimately contributing to better surgical outcomes and patient care.

Nexdot

Pre Seed Round in 2022
Nexdot is a company specializing in the development and production of semiconductor nanocrystals known as Quantum Dots, with a particular focus on nanoplatelets—two-dimensional nanosheet Quantum Dots that exhibit enhanced properties. Originating as a spin-off from a renowned academic laboratory in Paris, Nexdot leverages over a decade of expertise in nanomaterial research. The company has invested four years in intensive research and development to establish unique capabilities in the synthesis of colloidal Quantum Dots and Nanoplatelets. Their proprietary materials, characterized by controlled shape and composition, are designed for a variety of applications, including displays, lighting, energy storage, detectors, and bio-imaging. Nexdot combines a team of highly skilled, passionate scientists with seasoned executives who possess a strong background in management and innovation leadership, positioning the company as a leader in the field.

Enduro Genetics

Grant in 2022
Enduro Genetics is a technology provider that specializes in enhancing large-scale fermentations through its proprietary synthetic biology technology. The company focuses on improving the performance of fermentation processes by developing a genetic plugin technology that is free of antibiotic resistance genes. This innovation allows for higher yields by enriching spontaneous high producers within the fermentation population, facilitating the production of complex or cellular inhibit products by addressing strain instability. By maximizing the performance of cells derived from production strains, Enduro aims to bolster the competitiveness of both current and future green bioproduction initiatives.

Carmat

Grant in 2022
Carmat is a French medtech company that specializes in the development and manufacturing of bioprosthetic artificial hearts. Founded in 2008 and headquartered in Vélizy-Villacoublay, the company creates biocompatible, auto-regulated total artificial hearts designed to closely mimic the human heart's structure, including both right and left ventricles. These devices are intended for patients suffering from chronic terminal heart failure classified as class IV by the New York Heart Association, as well as those experiencing acute terminal heart failure due to massive myocardial infarction. Carmat aims to provide a reliable and innovative therapeutic solution for heart failure patients who are ineligible for transplants and have exhausted other treatment options. In addition to the artificial hearts, the company develops the necessary power supply systems and remote diagnostic systems for these devices.

InPhocal

Grant in 2022
InPhocal develops innovative laser-based marking technology. Its patented long-focus laser beam enables high-quality printing on curved and uneven surfaces, helping manufacturers, chip producers, and food distributors reduce waste, lower costs, and expand branding opportunities.

Carmat

Post in 2022
Carmat is a French medtech company that specializes in the development and manufacturing of bioprosthetic artificial hearts. Founded in 2008 and headquartered in Vélizy-Villacoublay, the company creates biocompatible, auto-regulated total artificial hearts designed to closely mimic the human heart's structure, including both right and left ventricles. These devices are intended for patients suffering from chronic terminal heart failure classified as class IV by the New York Heart Association, as well as those experiencing acute terminal heart failure due to massive myocardial infarction. Carmat aims to provide a reliable and innovative therapeutic solution for heart failure patients who are ineligible for transplants and have exhausted other treatment options. In addition to the artificial hearts, the company develops the necessary power supply systems and remote diagnostic systems for these devices.

Gold Standard Phantoms

Grant in 2022
Gold Standard Phantoms specializes in the development, marketing, and sale of calibration services and devices for quantitative medical imaging, particularly in the realm of MRI technology. The company manufactures cylindrical phantoms that streamline the preparation process by eliminating the need for multiple sample vials, facilitating more efficient calibration. Its offerings include a cloud-based data analysis platform that ensures traceability to standardized values, allowing clinicians, medical physicists, and radiographers to obtain consistent quantitative measurements of diseases across different patients, scanners, and clinical environments. By enhancing the precision of MRI imaging, Gold Standard Phantoms aims to improve diagnostic accuracy and potentially reduce healthcare costs.

Nano4Imaging

Grant in 2022
Nano4Imaging GmbH, established in 2011 and located in Aachen, Germany, specializes in the development and production of contrast agents and devices designed for in-vivo imaging of medical implants and minimally invasive devices. The company offers a range of products, including MRWire EmeryGlide, a magnetic resonance imaging (MRI) conditional guidewire, and various coatings under the MagnaFy brand that enhance the visibility of devices in different imaging modalities, such as MRI, computed tomography (CT), and X-ray. These innovations facilitate navigation and monitoring during medical interventions, particularly in the treatment of cardiovascular diseases and in radiotherapy. By leveraging advanced nanotechnology, Nano4Imaging aims to improve the accuracy of patient monitoring and intervention outcomes.

Cailabs

Series C in 2022
CAILabs SAS is a French deep tech company headquartered in Rennes, specializing in the design, development, and production of photonic solutions aimed at optimizing light utilization in various applications. Established in 2013, CAILabs focuses on innovative optical components, particularly through its patented Multi-Plane Light Conversion (MPLC) technology. The company provides a range of products, including mode multiplexers, light converters, and laser beam shaping solutions tailored for the telecommunications and industrial laser sectors. Its offerings are designed to enhance the performance of fiber optic networks and laser material processing, addressing critical challenges such as atmospheric turbulence and the need for efficient signal multiplexing. CAILabs aims to leverage its expertise and technological innovations to create reliable and cost-effective solutions for clients in the photonics industry.

Treble

Seed Round in 2022
Treble Technologies is a company that focuses on advanced wave-based sound simulation products tailored for the architecture, engineering, and construction (AEC) industry. It offers specialized acoustics design software that enables the creation of physically accurate and perceptually realistic virtual acoustics. This software aids in minimizing risks and ensuring that designs adhere to all relevant regulations and certification standards. Additionally, it streamlines the process of importing, exporting, and reconfiguring models, ultimately saving time and costs for users. Treble's services find applications across various sectors, including automotive design, building architecture, immersive reality, and artificial intelligence, supporting studios and artists in delivering high-quality projects.

Treble

Grant in 2022
Treble Technologies is a company that focuses on advanced wave-based sound simulation products tailored for the architecture, engineering, and construction (AEC) industry. It offers specialized acoustics design software that enables the creation of physically accurate and perceptually realistic virtual acoustics. This software aids in minimizing risks and ensuring that designs adhere to all relevant regulations and certification standards. Additionally, it streamlines the process of importing, exporting, and reconfiguring models, ultimately saving time and costs for users. Treble's services find applications across various sectors, including automotive design, building architecture, immersive reality, and artificial intelligence, supporting studios and artists in delivering high-quality projects.

ONO

Series A in 2022
Creating transformative change in urban mobility, making our cities cleaner and more enjoyable. We first focus on urban logistics, moving goods around the city in ways that are sustainable, efficient and cost-effective. Our vehicle and its modular platform system, with easily swappable modular units, meets the needs of city logistics. From moving food to flowers to furniture, the possibilities are endless. ONO’s founders, pioneer in e-mobility solutions, Beres Seelbach, former head of design at Mercedes and Volkswagen, Murat Günak, and light electric vehicle expert and engineer, Philipp Kahle, sought to rethink and reshape modern urban transportation. They put together a forward-thinking group of designers, engineers and creative thinkers who shared their vision of transforming urban mobility. ONO is a Berlin-based e-mobility company introducing a whole new category of emissions-free vehicle: the Pedal Assisted Transporter (PAT), combining the flexibility of a bicycle with the capacity and durability of a van. We offer environmentally friendly urban logistics solutions designed and optimised for cities of today.

ROSI

Series A in 2022
ROSI is a company based in Grenoble, France, focused on developing innovative technologies for the recycling and revalorization of raw materials within the photovoltaic industry. The company specializes in recovering ultra-pure silicon and other metals that are typically lost during the manufacturing of photovoltaic cells and at the end of a solar panel's life cycle. By addressing industrial waste generated during the solar wafer slicing process and capturing silicon fine particles lost during PV-silicon production, ROSI enables its clients to produce photovoltaic modules in a more sustainable and cost-effective manner.

BlinkIn

Grant in 2022
BlinkIN is a technology company that has developed a smart visual assistant to enhance customer support through augmented reality and artificial intelligence. Its primary product, a visual bot, functions as a virtual troubleshooting guide, enabling users to show their devices or machines via smartphone. The bot then provides step-by-step instructions on-screen to resolve technical issues, ensuring accuracy at each stage. In addition to this, BlinkIN offers a service called BlinkIN Expert, which allows customers to connect with specialists or local technicians through a simple SMS link, eliminating the need for installation. By transforming traditional audio tech support calls into more intuitive visual interactions, BlinkIN aims to improve the efficiency of customer support processes while reducing the need for on-site dispatches.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.